New opportunity for targeting systemic inflammation in patients with heart failure through leucocyte immunomodulation

Eur J Heart Fail. 2024 Mar;26(3):534-536. doi: 10.1002/ejhf.3177. Epub 2024 Feb 23.

Authors

Bertram Pitt¹, Sai Prasad N Iyer², H David Humes³

Affiliations

¹ Division of Internal Medicine (Emeritus), University of Michigan School of Medicine, Ann Arbor, MI, USA.
² SeaStar Medical, Denver, CO, USA.
³ Division of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.

PMID: 38390738
DOI: 10.1002/ejhf.3177

No abstract available

Publication types

Editorial

MeSH terms

Heart Failure* / immunology
Humans
Immunomodulation*
Inflammation* / immunology
Leukocytes* / immunology